Pseudomonas Aeruginosa

Staphylococcus aureus and Pseudomonas aeruginosa are the most likely organisms to be found with a history of injection drug use.

What our notes say

Study material on Pseudomonas Aeruginosa

Practice questions on Pseudomonas Aeruginosa

Which of the following β-lactam antibiotics is active against Pseudomonas aeruginosa?

Answer: B. Piperacillin is an extended-spectrum penicillin with anti-pseudomonal activity. It's often combined with tazobactam (a β-lactamase inhibitor) for broader coverage. Pseudomonas requires specific β-lactams with structural features allowing penetration through its outer membrane porins. --- ---

Which of the following β-lactam antibiotics is active against Pseudomonas aeruginosa?

Answer: B. Piperacillin is an extended-spectrum penicillin with anti-pseudomonal activity. It's often combined with tazobactam (a β-lactamase inhibitor) for broader coverage. Pseudomonas requires specific β-lactams with structural features allowing penetration through its outer membrane porins. --- ---

Green-blue pus with a fruity odor in a burn patient is characteristic of an infection with Pseudomonas aeruginosa. The green color is due to pyocyanin and the fruity odor is due to pyrazinamide production.

Answer: A. Pseudomonas aeruginosa is an opportunistic pathogen often associated with hospital-acquired infections, particularly in burn patients. It is known for producing characteristic pigments like pyocyanin (blue-green) and elastase, which contribute to the color and odor of the wound exudate.

A 72-year-old man is admitted to the hospital from a nursing home with severe pneumonia. He was discharged from the hospital 1 week ago after open heart surgery. The patient has no known allergies. Which of the following regimens is most appropriate for empiric coverage of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in this patient?

Answer: A. This patient is at high risk for healthcare-associated pneumonia (HAP) with resistant pathogens. Vancomycin provides MRSA coverage, and piperacillin-tazobactam provides broad-spectrum Gram-negative coverage, including Pseudomonas. Levofloxacin alone may not adequately cover MRSA, and ceftriaxone/azithromycin is insufficient for MRSA and Pseudomonas.

A 72-year-old man is admitted to the hospital from a nursing home with severe pneumonia. He was discharged from the hospital 1 week ago after open heart surgery. The patient has no known allergies. Which of the following regimens is most appropriate for empiric coverage of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in this patient with hospital-acquired pneumonia

Answer: C. This patient has risk factors for hospital-acquired pneumonia, including recent hospitalization and nursing home residence. Empiric coverage for MRSA (Vancomycin) and Pseudomonas aeruginosa (Piperacillin-tazobactam is an antipseudomonal beta-lactam) is appropriate for severe cases.

Which of the following statements regarding Pseudomonas aeruginosa is correct?

Answer: B. Pseudomonas aeruginosa is an opportunistic, Gram-negative rod that is ubiquitous in the environment. It frequently causes infections in patients with weakened immune systems, such as those with cystic fibrosis, burns, or prolonged hospitalization, often in healthcare settings.

Related topics